Across TCGA pan-cancer cohorts, CAPN10-DT RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of CAPN10-DT’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where CAPN10-DT RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CAPN10-DT is over-expressed in tumor.
COAD, BLCA, and LIHC are the cancer types where CAPN10-DT tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CAPN10-DT RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.